Protein, mTOR, and Aging: How Much Protein Actually Optimizes Longevity? (2026)

Here is a contradiction that has quietly tormented longevity researchers for over a decade: the single most reliable way to extend lifespan in laboratory animals is to restrict nutrients that activate growth signaling – and protein is the most potent activator of that signaling. Meanwhile, the single strongest predictor of whether a human over 65 will remain functionally independent, avoid falls, maintain metabolic health, and survive the next decade is muscle mass. And muscle mass requires protein.

Eat too much protein, and you accelerate the growth pathways (specifically mTOR) that drive cellular aging, cancer risk, and the suppression of autophagy. Eat too little, and you lose the muscle tissue that literally keeps you alive in the second half of life.

This is not a theoretical dilemma. A landmark 2014 study found that high protein intake in middle-aged adults was associated with a 75% increase in overall mortality and a fourfold increase in cancer death. The same study found that high protein intake in adults over 65 was protective – associated with reduced mortality. Same nutrient. Opposite effects. Depending on your age.

The protein-longevity question is not "how much?" It is "how much, when, what kind, and at what age?" This article is the full answer.

TL;DR – Key Takeaways

• Protein is the strongest dietary activator of mTOR (the growth-signaling pathway that accelerates aging when chronically elevated). Leucine is the specific amino acid that triggers mTOR most potently.
• The Levine et al. 2014 study (n=6,381) found high protein intake (>20% of calories) in adults 50-65 linked to 75% higher overall mortality and 4x cancer mortality – but this reversed after age 65, where high protein became protective.
• The reversal makes biological sense: middle-aged adults have robust muscle mass but accumulating cancer risk (mTOR fuels both muscle AND tumors). Older adults face sarcopenia (age-related muscle loss) as their primary threat.
• The PROT-AGE consensus recommends 1.0-1.2 g/kg/day for adults over 65 – significantly higher than the general RDA of 0.8 g/kg/day.
• Protein cycling – higher intake on training days to support muscle protein synthesis, lower intake on rest days to permit autophagy – may capture benefits of both mTOR activation and mTOR inhibition.
• Plant protein sources activate mTOR less aggressively than animal protein due to lower leucine content and different amino acid profiles.
• Approximately 2.5g of leucine per meal is the threshold for maximal muscle protein synthesis – this is the "leucine trigger" concept.
• Combining protein cycling with time-restricted eating may offer the best of both worlds: muscle preservation and autophagic renewal.

The Paradox: Why Protein Is Both Dangerous and Essential

The tension between protein and longevity sits at the intersection of two massive bodies of evidence that, on their surface, flatly contradict each other.

Evidence stream one: protein restriction extends lifespan. Decades of caloric restriction research have consistently shown that protein is the macronutrient most responsible for lifespan extension – not total calories. Solon-Biet et al. (2014, Cell Metabolism) conducted one of the most comprehensive diet studies ever performed in mice, testing 25 different macronutrient ratios across 858 animals. The finding: low-protein, high-carbohydrate diets produced the longest lifespans. The lowest-protein diets extended median lifespan by approximately 30% compared to the highest-protein diets, independent of total caloric intake. Total calories mattered – but protein mattered more.

The mechanism is well characterized. Protein – particularly amino acids like leucine and arginine – activates mTOR (mechanistic Target of Rapamycin, a growth-signaling pathway that, when chronically active, accelerates aging). Active mTOR suppresses autophagy (the cell's recycling system for clearing damaged components), promotes cell proliferation (including in pre-cancerous cells), and shifts cellular resources from repair to growth. Restrict protein, and mTOR goes quiet. Autophagy activates. Damaged cells get cleared. Cancer-promoting growth signals diminish. Organisms live longer.

Evidence stream two: muscle mass is the strongest predictor of healthy aging. Sarcopenia (the progressive, age-related loss of skeletal muscle mass and strength) begins around age 30 and accelerates after 60. Adults lose 3-8% of their muscle mass per decade after 30, with losses accelerating to 1-2% per year after 60. A 2014 analysis published in the American Journal of Medicine (Srikanthan & Karlamangla, n=3,659) found that muscle mass index was inversely associated with all-cause mortality – the more muscle, the lower the risk of death – independent of fat mass, metabolic syndrome, and traditional risk factors.

Muscle is not just for aesthetics or athletics. It is the body's largest glucose sink (disposing of ~80% of ingested glucose), a critical metabolic organ, the primary buffer against falls (the leading cause of injury-related death in adults over 65), and a reservoir of amino acids that the immune system draws on during illness. Losing it is catastrophic. And maintaining it requires protein – there is no way around this. Resistance training without adequate protein intake fails to produce meaningful hypertrophy in older adults.

So the paradox is real. Protein feeds the very pathway that drives aging. And protein builds the tissue that prevents the most common causes of death in the elderly. The question is how to navigate both truths simultaneously.

The Levine Study: The Paper That Changed the Conversation

In 2014, Valter Longo's group at the University of Southern California published a study that reframed the entire protein-longevity debate. It remains one of the most cited and most misunderstood papers in nutritional gerontology – and it sits at the center of one of the most consequential disagreements in longevity nutrition. Longo's recommendation, based on his IGF-1 research: low protein (0.31-0.36 g/lb) before age 65, then high protein after 65 to combat sarcopenia. Peter Attia disagrees fundamentally – he emphasizes higher protein intake throughout life (approximately 1 g/lb lean body mass) because in his framework, sarcopenia prevention outweighs the mTOR concerns at every age. This Longo vs. Attia debate represents the central tension in the field, and you will see both sides reflected in the data below.

Study Design

Levine et al. (Cell Metabolism, 2014) analyzed data from NHANES III (the Third National Health and Nutrition Examination Survey), a nationally representative cohort of 6,381 adults aged 50 and older, followed for 18 years. Participants were categorized by protein intake as a percentage of total calories:

• High protein: 20% or more of calories from protein
• Moderate protein: 10-19% of calories from protein
• Low protein: less than 10% of calories from protein

The Headline Finding

Among respondents aged 50-65:

• High protein intake was associated with a 75% increase in overall mortality (HR 1.74, 95% CI 1.02-2.97)
• High protein intake was associated with a 4-fold increase in cancer mortality (HR 4.33, 95% CI 1.96-9.56)
• These associations were comparable in magnitude to the mortality risk of smoking

The numbers were striking – and the media coverage was predictably reductive. "Eating meat is as bad as smoking" became the headline. But the actual findings were far more nuanced.

The Age-Dependent Reversal

Here is what most coverage missed: the effect reversed after age 65.

Among respondents aged 66 and older:

• High protein intake was associated with a 28% reduction in overall mortality (HR 0.72)
• High protein intake was associated with a 60% reduction in cancer mortality (HR 0.40)

Same nutrient. Same study. Opposite effects. The dividing line was approximately age 65.

The IGF-1 Connection

Levine et al. went further. They measured IGF-1 (insulin-like growth factor 1 – a growth hormone that promotes cell proliferation and is closely linked to cancer risk) levels and found that the protein-mortality association was substantially mediated by IGF-1. Subjects with both high protein intake and high IGF-1 levels had the greatest cancer mortality risk. When IGF-1 was controlled for, the protein-mortality association weakened.

This matters because IGF-1 levels naturally decline with age. By 65-70, most adults have significantly lower circulating IGF-1 than they did at 50. The biological context changes: the same protein intake produces a different hormonal and signaling environment in a 70-year-old than in a 55-year-old.

The Animal vs. Plant Protein Distinction

The study also found that when the analysis was restricted to plant-derived protein, the mortality associations largely disappeared. The 75% mortality increase and 4x cancer death risk were primarily driven by animal protein sources. Plant protein, even at high intake levels, did not carry the same risk profile.

Important Limitations

This was an observational study with self-reported dietary data. It cannot prove causation. Residual confounding is possible – people who eat high-protein diets may differ from those who eat low-protein diets in ways not captured by the survey (exercise habits, socioeconomic factors, overall dietary quality). The dietary data came from a single 24-hour recall, which is a notoriously imprecise method.

That said, the findings are biologically plausible, mechanistically consistent with the mTOR literature, supported by the IGF-1 mediation analysis, and reproduced in multiple subsequent observational studies.

Key Takeaway: The Levine 2014 study found that high protein intake (>20% of calories) in adults 50-65 was associated with a 75% increase in overall mortality and a 4-fold increase in cancer death. But after 65, the association reversed — high protein became protective. This age-dependent switch is the key insight: protein needs are not fixed; they change dramatically across the lifespan.

mTOR and Protein: The Molecular Mechanism

To understand why protein affects aging, you need to understand how protein activates mTOR – and why that activation matters.

How Amino Acids Activate mTOR

mTORC1 (the mTOR complex most relevant to aging) is activated by amino acids through a sensing mechanism at the lysosomal surface. The process works like this:

1. Amino acid sensing. When intracellular amino acid concentrations rise after a protein-rich meal, specific sensor proteins detect the increase. Sestrin2 senses leucine. CASTOR1 senses arginine. SAMTOR senses methionine (indirectly, via S-adenosylmethionine).
2. Rag GTPase activation. The amino acid sensors regulate a set of GTPases (enzymes that act as molecular switches) called the Rag proteins. When amino acids are present, the Rag GTPases switch to their active configuration.
3. Lysosomal recruitment. Active Rag GTPases recruit mTORC1 to the lysosomal surface, where it encounters Rheb (Ras homolog enriched in brain) – the direct activator of mTORC1.
4. Full activation. If Rheb is also in its active state (which depends on insulin/IGF-1 signaling through the PI3K/Akt/TSC pathway), mTORC1 is fully activated and begins phosphorylating its downstream targets: S6K1 (for protein synthesis), 4E-BP1 (for cap-dependent translation), and ULK1 (to suppress autophagy).

The key insight: amino acids are necessary but not sufficient for full mTOR activation. The system requires both amino acid sensing (for lysosomal recruitment) and growth factor signaling (for Rheb activation). This is why protein in the context of a high-insulin environment (a mixed meal with carbohydrates) produces stronger mTOR activation than protein consumed alone.

Not All Amino Acids Are Equal

Among the 20 amino acids, three stand out as mTOR activators:

• Leucine – the most potent mTORC1 activator, sensed by Sestrin2
• Arginine – sensed by CASTOR1 and SLC38A9
• Methionine – sensed indirectly through SAM levels via SAMTOR

Leucine deserves special attention because it is the amino acid most directly responsible for both the muscle-building and the aging-acceleration effects of dietary protein.

Leucine: The Master Switch

Leucine is a branched-chain amino acid (BCAA – one of three amino acids with a branched molecular structure: leucine, isoleucine, and valine) that occupies a unique position in protein biology. It is simultaneously the strongest trigger of muscle protein synthesis (MPS) and the strongest dietary activator of mTORC1.

The Leucine Trigger Hypothesis

Donald Layman's research group (2015, The Journal of Nutrition) established what has become known as the "leucine trigger" concept: there is a threshold amount of leucine required per meal to maximally stimulate muscle protein synthesis. Below this threshold, MPS is submaximal. Above it, there is no additional benefit – the response plateaus.

That threshold is approximately 2.5 grams of leucine per meal in young adults, and likely 3.0-3.5 grams per meal in older adults (due to anabolic resistance – the age-related blunting of the muscle protein synthesis response to amino acids).

To put that in food terms:

Notice the discrepancy between animal and plant sources. This is not trivial – it is central to the protein-longevity debate.

The Leucine Paradox

Here is the problem: the same leucine threshold that triggers maximal muscle protein synthesis also triggers robust mTORC1 activation. You cannot stimulate MPS without activating mTOR – they are the same pathway. S6K1 (ribosomal protein S6 kinase 1 – a direct mTORC1 target) is the mediator of both effects.

This means every meal that effectively stimulates muscle growth also effectively suppresses autophagy for the duration of that mTOR activation (typically 3-5 hours post-meal). Three protein-rich meals per day means mTOR is active for most of your waking hours. Autophagy barely gets a window to operate.

For a young adult who needs to build or maintain muscle, this trade-off is acceptable – the aging-acceleration cost of mTOR activation is low relative to the muscle-building benefit. For a middle-aged adult with stable muscle mass and rising cancer risk, the calculus starts shifting.

Key Takeaway: Dietary protein activates mTOR through amino acid sensing — particularly leucine, which activates mTOR via the Rag GTPase pathway. Chronic mTOR overactivation suppresses autophagy, promotes cellular senescence, and is consistently associated with shorter lifespan across species. The protein-mTOR connection explains why protein restriction extends lifespan in younger animals while protein adequacy protects against sarcopenia in older ones.

The Age-Dependent Switch: Why Protein Needs Change Over a Lifetime

The Levine et al. findings are not an anomaly. They reflect a genuine biological transition in how the body handles protein at different life stages. Understanding this transition is essential for making rational protein decisions.

Ages 20-50: Growth Signaling Is High-Risk

During this period:

• IGF-1 levels are at or near their lifetime peak. This means the mTOR pathway is already primed for activation. Additional protein amplifies an already-active growth signal.
• Muscle mass is relatively easy to maintain. The anabolic response to resistance training is strong. Moderate protein intake (0.8-1.0 g/kg/day) combined with resistance training is usually sufficient to maintain or even build muscle.
• Cancer risk is accumulating. Most cancers develop over decades. The pre-cancerous cells that will become clinical cancers in the 50s and 60s are already present and sensitive to growth signaling. mTOR activation promotes their proliferation.
• Autophagy capacity is still relatively robust. The cellular recycling machinery has not yet significantly declined.

The implication: For most adults under 50, the marginal risk of excessive mTOR activation from high protein intake likely outweighs the marginal benefit to muscle mass. The evidence favors moderate protein intake with attention to overall mTOR-suppressing behaviors (fasting, exercise, reduced processed food).

Ages 50-65: The Transition Zone

This is the most complex period. The Levine data shows that high protein is still risky here – 75% higher mortality. But muscle loss is accelerating, and the consequences of sarcopenia are beginning to materialize.

• IGF-1 is declining but still meaningful. The cancer-promoting effects of high protein are still relevant.
• Anabolic resistance is emerging. The muscle protein synthesis response to a given protein dose begins to blunt. Older muscle requires more protein (and more leucine) per meal to achieve the same anabolic stimulus as younger muscle.
• Cancer screening becomes more important. The interaction between protein intake and cancer risk makes regular screening particularly relevant during this period.

The implication: This is the age range where protein quality and timing begin to matter more than total quantity. Consolidating protein into fewer, larger meals (rather than spreading it across many small meals) may provide adequate leucine triggers for MPS while leaving longer interprandial windows for mTOR suppression and autophagy. This is where the protein cycling concept (discussed below) becomes most relevant.

Ages 65+: The Reversal

After 65, the risk-benefit equation flips:

• IGF-1 levels are significantly lower. The cancer-promoting effect of protein-driven mTOR activation is attenuated because the amplification signal (IGF-1) has naturally declined.
• Sarcopenia is now the primary threat. Falls, frailty, loss of independence, impaired glucose disposal, immune compromise – the downstream consequences of muscle loss become the dominant risks.
• Anabolic resistance is pronounced. Older adults need more protein per meal, more leucine per meal, and more total daily protein to achieve the same muscle-preserving effect as younger adults.
• Autophagy is already impaired. The cellular recycling machinery has declined regardless of dietary protein intake. Protein restriction offers diminishing marginal returns for autophagy activation in this age group.

The implication: The PROT-AGE Study Group (an international consortium of geriatric nutrition researchers) published their consensus in 2013 (Journal of the American Medical Directors Association): adults over 65 should consume 1.0-1.2 g/kg/day of protein, and those with acute or chronic illness should consume 1.2-1.5 g/kg/day. This is 25-50% higher than the general RDA of 0.8 g/kg/day.

The more recent ESPEN (European Society for Clinical Nutrition and Metabolism) guidelines (2019) reinforced this, recommending 1.0-1.2 g/kg/day as a minimum for healthy older adults and up to 1.5 g/kg/day for those with sarcopenia or recovering from illness.

Animal Protein vs. Plant Protein: The Longevity Distinction

The Levine et al. finding that plant protein did not carry the same mortality risk as animal protein is consistent with a growing body of evidence suggesting that protein source matters for longevity, independent of total protein intake.

Why Animal Protein Activates mTOR More Aggressively

Three factors contribute:

1. Higher leucine content. Animal proteins contain approximately 8-10% leucine by weight. Plant proteins contain approximately 6-7%. This means animal protein reaches the leucine trigger threshold at lower total protein intakes, producing more frequent and more robust mTOR activation.
2. Higher methionine content. Methionine restriction independently extends lifespan in rodent models (Orentreich et al., 1993; Miller et al., 2005). Animal proteins are substantially richer in methionine than plant proteins. A plant-based diet naturally produces moderate methionine restriction.
3. Complete amino acid profile. Animal proteins provide all essential amino acids in proportions that closely match human requirements. This produces a stronger, more synchronized anabolic signal than plant proteins, which typically have one or more limiting amino acids (lysine in grains, methionine in legumes). The "incomplete" amino acid profile of plant proteins may paradoxically be a longevity advantage – it produces enough protein for maintenance without maximally stimulating the growth pathways.

The Epidemiological Evidence

A 2020 study (Huang et al., JAMA Internal Medicine, n=416,104, median follow-up 16 years) found that substituting 3% of energy from animal protein with plant protein was associated with:

• 10% lower overall mortality (HR 0.90, 95% CI 0.86-0.95)
• The greatest benefits came from replacing processed red meat and egg protein with plant sources

Song et al. (2016, JAMA Internal Medicine, n=131,342 from the Nurses' Health Study and Health Professionals Follow-up Study, follow-up up to 32 years) found that animal protein intake was positively associated with cardiovascular mortality, while plant protein intake was inversely associated with both cardiovascular and all-cause mortality. Each 10% increase in calories from animal protein was associated with an 8% higher risk of cardiovascular death. Each 3% increase from plant protein was associated with a 10% lower risk.

The Practical Middle Ground

None of this means animal protein is poison. It means the amount and frequency of animal protein consumption interact with mTOR signaling in ways that matter for long-term health outcomes.

A practical approach:

• Prioritize plant protein sources for baseline intake (legumes, soy, nuts, seeds, whole grains)
• Use animal protein strategically – on training days, in the post-workout meal, where the mTOR activation is channeled into productive muscle synthesis rather than generalized growth signaling
• Limit processed red meat (this is the category most consistently associated with mortality in the epidemiological literature)
• Fish and poultry appear neutral to beneficial in most longevity cohort studies

Protein Cycling: The Emerging Strategy

The concept of protein cycling – systematically alternating between higher-protein and lower-protein days – is gaining traction as a potential way to capture both mTOR activation (for muscle) and mTOR inhibition (for autophagy and longevity) without permanently sacrificing either.

The Theoretical Basis

The mTOR and AMPK pathways operate as a molecular seesaw. mTOR drives growth. AMPK drives repair. You cannot maximally activate both simultaneously. But you can alternate.

On high-protein/training days:

• Resistance training creates a demand for muscle protein synthesis
• Adequate protein (and leucine) activates mTOR to meet that demand
• The mTOR activation is "directed" – channeled into skeletal muscle repair and hypertrophy rather than generalized cell proliferation
• Exercise-induced AMPK activation in the hours before the protein meal may actually enhance the subsequent mTOR-driven anabolic response (the "AMPK-to-mTOR switch" observed in trained muscle)

On low-protein/rest days:

• Reduced amino acid intake allows mTOR to deactivate
• AMPK activity rises
• Autophagy is permitted to operate for extended windows
• Damaged proteins and organelles are cleared
• Cellular quality control catches up

What the Evidence Shows So Far

Direct long-term human trials of protein cycling for longevity outcomes do not yet exist. But several lines of evidence support the concept:

Intermittent protein restriction in mice. Brandhorst et al. (2015, Cell Metabolism) tested a fasting-mimicking diet (FMD) – periodic 4-day cycles of reduced calorie and protein intake, followed by ad libitum refeeding. Mice on the FMD showed reduced IGF-1, reduced cancer incidence, reduced inflammatory markers, improved immune cell regeneration, and extended healthspan. The protein restriction component appeared to be a key driver of these effects.

The exercise-protein interaction. Multiple studies have shown that resistance training sensitizes muscle to protein intake – trained muscle shows an enhanced MPS response to a given leucine stimulus compared to untrained muscle (Burd et al., 2011, Journal of Physiology). This means you may be able to achieve adequate muscle stimulus with lower total protein intake on training days than you would need without exercise.

Leucine pulsing studies. Research by Paddon-Jones and Rasmussen (2009, Current Opinion in Clinical Nutrition and Metabolic Care) demonstrated that distributing protein into leucine-threshold doses spread across fewer meals (rather than many small sub-threshold servings) produced superior muscle protein synthesis. This supports the concept of concentrated protein boluses rather than constant protein availability.

A Practical Protein Cycling Framework

The idea is not to chronically restrict protein – it is to create temporal variation in mTOR signaling. Some days you build. Some days you clean. The body does both, just not simultaneously.

Safety Note: Individuals with chronic kidney disease should consult a nephrologist before increasing protein intake, as high protein loads increase renal workload. If you take mTOR-inhibiting medications (rapamycin/sirolimus), discuss protein timing with your prescriber, as protein intake directly activates the mTOR pathway these drugs target.

Key Takeaway: Before age 65, moderate protein (0.8-1.0g/kg/day) with periodic protein fasting may optimize the mTOR-AMPK balance. After 65, sarcopenia risk overtakes mTOR concerns — increase to 1.2-1.6g/kg/day to preserve muscle mass. Active adults at any age need 1.2-2.0g/kg/day. The critical variable is not total protein but the timing and distribution across meals.

Practical Protein Recommendations by Age and Activity

The following table synthesizes the evidence from the Levine study, the PROT-AGE consensus, the leucine threshold research, and the emerging protein cycling data into actionable targets.

Daily Protein Intake Targets

Notes:

• All values are grams of protein per kilogram of body weight per day
• "Resistance Training" assumes 2-4 sessions per week with progressive overload
• For adults 50-65, emphasize protein cycling (higher on training days, lower on rest days) and prioritize plant protein for non-training meals
• For adults 65+, hitting the minimum target consistently matters more than cycling – sarcopenia risk outweighs mTOR concerns
• Obese individuals should calculate based on lean body mass or adjusted body weight, not total body weight

Per-Meal Protein Distribution

The increase in per-meal requirements with age reflects anabolic resistance – older muscle needs a stronger signal to initiate the same protein synthesis response. This is why many geriatric nutrition researchers now recommend fewer, larger protein meals rather than frequent small ones for adults over 65.

Combining Protein Strategy with Fasting

Time-restricted eating (TRE – limiting food intake to a defined window, typically 8-10 hours) is one of the most practical ways to create daily mTOR suppression windows without formal caloric restriction. When combined with a thoughtful protein strategy, it can address both the muscle-preservation and autophagy-activation sides of the paradox.

The Integration Model

Training days (e.g., resistance training at 7am):

• First meal (post-workout, ~8am): High-protein meal (30-40g protein, >2.5g leucine). This is the meal where animal protein is most justified – mTOR activation is channeled into exercised muscle.
• Second meal (~1pm): Moderate protein (25-30g), mixed or plant-based.
• Third meal (~5pm): Moderate protein (20-25g), plant-dominant. Eating window closes.
• 14-hour overnight fast: mTOR suppression, AMPK activation, autophagy window.

Rest days (no resistance training):

• First meal (~12pm): Moderate protein (20-25g), plant-based. Later eating start = extended fasting window.
• Second meal (~6pm): Moderate protein (20-25g), plant-based. Eating window closes.
• 18-hour overnight fast: Extended mTOR suppression, deeper autophagy activation.

This creates a weekly rhythm: 3-4 days of adequate mTOR activation directed into trained muscle, alternating with 3-4 days of extended mTOR suppression for cellular maintenance. For evidence profiles of compounds that modulate the mTOR-AMPK axis, see the Compound Index. The total weekly protein intake remains adequate for muscle preservation, but the distribution creates temporal variation in growth and repair signaling.

What Breaks Autophagy Fastest

Not all calories suppress autophagy equally. Protein (specifically leucine) is the most potent autophagy suppressor via direct mTOR activation. Carbohydrates suppress autophagy indirectly via insulin-mediated mTOR activation. Fat has the weakest effect on mTOR – which is why some fasting protocols permit small amounts of fat (MCT oil, black coffee with cream) during the fasting window without fully interrupting autophagic flux.

For maximizing autophagy during fasting windows: avoid protein and carbohydrates entirely. Black coffee, plain tea, water, and electrolytes are the safest options.

Frequently Asked Questions

Related Reading

• mTOR and AMPK: The Two Master Switches That Control How You Age
• Rapamycin: The Most Studied Anti-Aging Drug in History
• Exercise and Longevity: What Actually Moves the Needle
• Autophagy Explained: Cellular Recycling, Fasting, Exercise, and Aging
• Caloric Restriction Mimetics: Compounds That Mimic Fasting Without Fasting
• Intermittent Fasting and Longevity Supplements: Complete Timing Guide
• Strength Training for Longevity: Why Muscle Is a Survival Organ

The Bottom Line: The protein-longevity paradox has a resolution -- moderate protein before 65 (with cycling and plant-source emphasis), higher protein after 65 to fight sarcopenia, and deliberate meal timing to create windows where mTOR is on for muscle and off for cellular cleanup.

This article is for informational purposes only and does not constitute medical advice. Consult a healthcare provider before making significant changes to your diet, particularly if you have kidney disease, diabetes, or other metabolic conditions. Protein requirements vary significantly based on individual health status, body composition, and activity level.

Found this useful? Subscribe to the Daily Compounds Journal for evidence-based longevity science, delivered weekly. No hype, no sponsored content – just the research that matters.